Table 1 Baseline characteristics
Characteristics | Study population n = 11,968 | |
|---|---|---|
Demographic characteristics | ||
Age (years), mean (SD) | 62.1 | (16.6) |
Female sex, N (%) | 4,730 | (39.5) |
Clinical characteristics | ||
Length of stay, median (IQR) | 8 | (5–14) |
Continuity of care (discharged to another facility), N (%) | 1,513 | (12.6) |
High-tech hospital, N (%) | 8,118 | (67.8) |
ICU unit, N (%) | 3,473 | (29.0) |
Underlying disease, N (%) | 7,064 | (59.0) |
Arterial hypertension or chronic heart failure, N (%) | 4,628 | (38.7) |
Diabetes or chronic kidney disease, N (%) | 3,050 | (25.5) |
Chronic respiratory disease, N (%) | 1,432 | (12.0) |
Cancer, N (%) | 749 | (6.3) |
Neurodegenerative disease, N (%) | 122 | (1.0) |
Chronic liver disease, N (%) | 125 | (1.0) |
Immunosuppression, N (%) | 100 | (0.8) |
VIDA score | ||
Low risk (0), N (%) | 1,495 | (12.5) |
Moderate risk (1–2), N (%) | 7,354 | (61.4) |
High risk (3–4), N (%) | 3,119 | (26.1) |